TGFB1 and B-cell chronic lymphocytic leukemia: While its specific role in CLL-induced NK inhibition has not been established, TGFβ inhibits NK cells by decreasing the expression of activating receptors and cytotoxic molecules, altering NK metabolism, and inhibiting cytokine production [149,150,151].